A photo of Shabana Shahanavaz.

Shabana Shahanavaz, MD, MBBS


  • Director, Cardiac Catheterization Laboratory, The Heart Institute
  • Associate Professor, UC Department of Pediatrics
I have a passion for helping patients by being involved in multi-center trials and projects. These trials focus on developing interventional cardiology technology and a better understanding of available therapies to benefit patients around the world.
Shabana Shahanavaz, MD, MBBS

About

Biography

I’m a pediatric cardiologist specializing in congenital heart disease and interventional cardiology. I have a passion for helping patients by being involved in multi-center trials and projects. These trials focus on developing interventional cardiology technology and a better understanding of available therapies to benefit patients around the world.

I was inspired to become a pediatric cardiologist by members of my extended family, who were physicians. As director of the Cardiac Catheterization Laboratory at Cincinnati Children’s, I have clinical expertise in performing complex diagnostic and interventional cardiac catheterization instead of open-heart surgery or adjunct to surgical procedures.

When I worked in St. Louis, Missouri, I received the Best Doctor award in 2019 and 2020.

My research is focused on catheter-based intervention to treat congenital heart defects, clinical trials in congenital interventional catheterization, and innovations.

I enjoy spending my free time with my family.

MBBS: Kasturba Medical College, Karnataka, India, 2002.

Residency: Pediatrics, Children's Hospital of Brooklyn, Brooklyn, NY, 2007.

Fellowship: Cardiology, University of California San Francisco, San Francisco, CA, 2010.

Fellowship: 4th year Advanced Fellowship in Interventional Cardiology, Morgan Stanley Children's Hospital, Manhattan, NY, 2011.

Interests

Passion and clinical expertise in performing complex diagnostic and interventional cardiac catheterization in lieu of open heart surgery or as an adjunct to surgical procedures

Services and Specialties

Heart, Catheterization and Intervention

Interests

Research focused on catheter-based intervention for treatment of congenital heart defects, clinical trials in congenital interventional catheterization, and innovations

Research Areas

Heart

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis. Goldberg, DJ; Hu, C; Lubert, AM; Rathod, RH; Penny, DJ; Petit, CJ; Schumacher, KR; Ginde, S; Williams, RV; Yoon, JK; et al. Pediatric Cardiology. 2023; 44:1691-1701.

Right atrial thrombus removal with use of the ŌNŌ retrieval device. Herron, C; Batlivala, SP; Shahanavaz, S. Catheterization and Cardiovascular Interventions. 2023; 102:1105-1108.

Abstract 12267: Timing and Mode of Death Following Treatment of Neonatal Symptomatic Tetralogy of Fallot. Trucco, SM; Zhang, Y; McCracken, C; Glatz, AC; Petit, CJ; Qureshi, AM; Zampi, J; Shahanavaz, S; Nicholson, G; Abejero, N; et al. Circulation. 2023; 148.

Abstract 14744: Driving Distance to a Primary Cardiac Center is Associated With Mortality in Patients With Tetralogy of Fallot Undergoing Neonatal Interventions. Nunez Gallegos, F; Maskatia, SA; Zampi, J; Nicholson, G; Zhang, Y; McCracken, C; Mascio, C; Petit, CJ; Romano, J; Zanaboni, D; et al. Circulation. 2023; 148.

Outcomes Following Balloon Pulmonary Valvuloplasty in Symptomatic Neonates With Tetralogy of Fallot—A CCRC Study. Shahanavaz, S; Qureshi, AM; Petit, CJ; Goldstein, BH; Glatz, AC; Bauser-Heaton, H; McCracken, CE; Kelleman, MS; Nicholson, GT; Zampi, JD; et al. Journal of the Society for Cardiovascular Angiography & Interventions. 2023; 2:101062.

Use of mechanical thrombectomy in very early-onset inflammatory bowel disease patient with extensive venous thrombosis. Herron, C; McGovern, E; Shahanavaz, S. Cardiology in the Young. 2023; 33:2405-2407.

3-year follow-up of a prospective, multicenter study of the Amplatzer Piccolo™ Occluder for transcatheter patent ductus arteriosus closure in children ≥ 700 grams. Morray, BH; Sathanandam, SK; Forbes, T; Gillespie, M; Berman, D; Armstrong, AK; Shahanavaz, S; Jones, T; Rockefeller, T; Justino, H; et al. Journal of Perinatology. 2023; 43:1238-1244.

Comparison of treatment strategies for neonates with tetralogy of Fallot and pulmonary atresia. Meadows, JJ; Bauser-Heaton, H; Petit, CJ; Goldstein, BH; Qureshi, AM; McCracken, CE; Kelleman, MS; Nicholson, GT; Law, MA; Zampi, JD; et al. Journal of Thoracic and Cardiovascular Surgery. 2023; 166:916-925.e6.

Pulmonary Artery Hypoplasia in Neonates With Tetralogy of Fallot. Petit, CJ; Glatz, AC; Goldstone, AB; Law, MA; Romano, JC; Maskatia, SA; Chai, PJ; Zampi, JD; Meadows, JJ; Nicholson, GT; et al. Journal of the American College of Cardiology. 2023; 82:615-627.

Safety and Short-Term Outcomes for Infants < 2.5 kg Undergoing PDA Device Closure: A C3PO Registry Study. Barry, OM; Gudausky, TM; Balzer, DT; Bocks, ML; Boe, BA; Callahan, R; El-Said, H; Farias, MJ; Foerster, S; Goldstein, BH; et al. Pediatric Cardiology. 2023; 44:1406-1413.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating